The creamy layer - amongst the top performing stocks

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Oxygenta Pharmaceutical Limited manufactures bulk drugs and active pharmaceutical ingredients (API), including a range of pharmaceutical preparations and organic fine chemicals.

Oxygenta Pharmaceutical Ltd

With a market cap of ₹326 cr, stock is ranked 2,158

Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Ltd

Scorecard

News & Opinions